BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sengupta V, Sengupta S, Lazo A, Woods P, Nolan A, Bremer N. Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19. Stem Cells Dev. 2020;29:747-754. [PMID: 32380908 DOI: 10.1089/scd.2020.0080] [Cited by in Crossref: 142] [Cited by in F6Publishing: 158] [Article Influence: 71.0] [Reference Citation Analysis]
Number Citing Articles
1 Jahangiri B, Saei AK, Obi PO, Asghari N, Lorzadeh S, Hekmatirad S, Rahmati M, Velayatipour F, Asghari MH, Saleem A, Moosavi MA. Exosomes, autophagy and ER stress pathways in human diseases: Cross-regulation and therapeutic approaches. Biochim Biophys Acta Mol Basis Dis 2022;1868:166484. [PMID: 35811032 DOI: 10.1016/j.bbadis.2022.166484] [Reference Citation Analysis]
2 Huang Y, Li X, Yang L. Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment. Stem Cell Res Ther 2022;13:410. [PMID: 35962458 DOI: 10.1186/s13287-022-03034-4] [Reference Citation Analysis]
3 Liu C, Xiao K, Xie L. Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome. Front Cell Dev Biol 2022;10:951764. [DOI: 10.3389/fcell.2022.951764] [Reference Citation Analysis]
4 Liu C, Xiao K, Xie L. Advances in the use of exosomes for the treatment of ALI/ARDS. Front Immunol 2022;13:971189. [DOI: 10.3389/fimmu.2022.971189] [Reference Citation Analysis]
5 Tamura T, Yoshioka Y, Sakamoto S, Ichikawa T, Ochiya T. Extracellular vesicles in bone homeostasis: key roles of physiological and pathological conditions. J Bone Miner Metab 2022. [PMID: 35943593 DOI: 10.1007/s00774-022-01362-2] [Reference Citation Analysis]
6 Chen CY, Chen WC, Hsu CK, Chao CM, Lai CC. The clinical efficacy and safety of mesenchymal stromal cells for patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. J Infect Public Health 2022;15:896-901. [PMID: 35849852 DOI: 10.1016/j.jiph.2022.07.001] [Reference Citation Analysis]
7 Sapra L, Saini C, Garg B, Gupta R, Verma B, Mishra PK, Srivastava RK. Long-term implications of COVID-19 on bone health: pathophysiology and therapeutics. Inflamm Res 2022. [PMID: 35900380 DOI: 10.1007/s00011-022-01616-9] [Reference Citation Analysis]
8 Tan MI, Alfarafisa NM, Septiani P, Barlian A, Firmansyah M, Faizal A, Melani L, Nugrahapraja H. Potential Cell-Based and Cell-Free Therapy for Patients with COVID-19. Cells 2022;11:2319. [DOI: 10.3390/cells11152319] [Reference Citation Analysis]
9 Crum RJ, Capella-monsonís H, Badylak SF, Hussey GS. Extracellular Vesicles for Regenerative Medicine Applications. Applied Sciences 2022;12:7472. [DOI: 10.3390/app12157472] [Reference Citation Analysis]
10 Zhou L, Luo H, Lee JW. Role of extracellular vesicles in lung diseases. Chin Med J (Engl) 2022. [PMID: 35866573 DOI: 10.1097/CM9.0000000000002118] [Reference Citation Analysis]
11 Lebeau G, Ah-pine F, Daniel M, Bedoui Y, Vagner D, Frumence E, Gasque P. Perivascular Mesenchymal Stem/Stromal Cells, an Immune Privileged Niche for Viruses? IJMS 2022;23:8038. [DOI: 10.3390/ijms23148038] [Reference Citation Analysis]
12 Manoharan R, Kore RA, Mehta JL. Mesenchymal stem cell treatment for hyperactive immune response in patients with COVID-19. Immunotherapy 2022. [PMID: 35855633 DOI: 10.2217/imt-2021-0245] [Reference Citation Analysis]
13 Li M, Fang F, Sun M, Zhang Y, Hu M, Zhang J. Extracellular vesicles as bioactive nanotherapeutics: An emerging paradigm for regenerative medicine. Theranostics 2022;12:4879-903. [PMID: 35836815 DOI: 10.7150/thno.72812] [Reference Citation Analysis]
14 Shimon MB, Shapira S, Seni J, Arber N. The Big Potential of Small Particles: Lipid-Based Nanoparticles and Exosomes in Vaccination. Vaccines 2022;10:1119. [DOI: 10.3390/vaccines10071119] [Reference Citation Analysis]
15 Chaudhary JK, Saini D, Chaudhary PK, Maurya A, Verma GK, Gupta AK, Roshan R, Vats TK, Garg N, Yadav D, Kant N, Meena AK, Mirza-shariff AA. Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19. Cells 2022;11:2175. [DOI: 10.3390/cells11142175] [Reference Citation Analysis]
16 Popowski KD, Moatti A, Scull G, Silkstone D, Lutz H, López de Juan Abad B, George A, Belcher E, Zhu D, Mei X, Cheng X, Cislo M, Ghodsi A, Cai Y, Huang K, Li J, Brown AC, Greenbaum A, Dinh PC, Cheng K. Inhalable dry powder mRNA vaccines based on extracellular vesicles. Matter 2022. [PMID: 35847197 DOI: 10.1016/j.matt.2022.06.012] [Reference Citation Analysis]
17 Rossello-Gelabert M, Gonzalez-Pujana A, Igartua M, Santos-Vizcaino E, Hernandez RM. Clinical progress in MSC-based therapies for the management of severe COVID-19. Cytokine Growth Factor Rev 2022:S1359-6101(22)00050-8. [PMID: 35843774 DOI: 10.1016/j.cytogfr.2022.07.002] [Reference Citation Analysis]
18 Boland L, Bitterlich LM, Hogan AE, Ankrum JA, English K. Translating MSC Therapy in the Age of Obesity. Front Immunol 2022;13:943333. [DOI: 10.3389/fimmu.2022.943333] [Reference Citation Analysis]
19 Arango-rodríguez ML, Solarte-david VA, Becerra-bayona SM, Callegari E, Paez MD, Sossa CL, Vera MEO, Mateus LC, Eduardo serrano S, Ardila-roa AK, Viviescas LTG. Role of mesenchymal stromal cells derivatives in diabetic foot ulcers: a controlled randomized phase 1/2 clinical trial. Cytotherapy 2022. [DOI: 10.1016/j.jcyt.2022.04.002] [Reference Citation Analysis]
20 Li YE, Ajoolabady A, Dhanasekaran M, Ren J. Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy. Pharmacol Res 2022;182:106334. [PMID: 35779816 DOI: 10.1016/j.phrs.2022.106334] [Reference Citation Analysis]
21 Hu C, Jiang W, Lv M, Fan S, Lu Y, Wu Q, Pi J. Potentiality of Exosomal Proteins as Novel Cancer Biomarkers for Liquid Biopsy. Front Immunol 2022;13:792046. [PMID: 35757760 DOI: 10.3389/fimmu.2022.792046] [Reference Citation Analysis]
22 Kakabadze Z, Kipshidze N, Paresishvili T, Kipshidze N, Vadachkoria Z, Chakhunashvili D. Human Placental Mesenchymal Stem Cells for the Treatment of ARDS in Rat. Stem Cells Int 2022;2022:8418509. [PMID: 35756754 DOI: 10.1155/2022/8418509] [Reference Citation Analysis]
23 Cuevas-González MV, Cuevas-González JC. Stem cells as an option for the treatment of COVID-19. World J Clin Cases 2022; 10(18): 6338-6340 [DOI: 10.12998/wjcc.v10.i18.6338] [Reference Citation Analysis]
24 Arias M, Oliveros H, Lechtig S, Bustos R. Biologics in COVID-19 So Far: Systematic Review. Pharmaceuticals 2022;15:783. [DOI: 10.3390/ph15070783] [Reference Citation Analysis]
25 Bahmani L, Ullah M. Different Sourced Extracellular Vesicles and Their Potential Applications in Clinical Treatments. Cells 2022;11:1989. [DOI: 10.3390/cells11131989] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Hu X, Jia C, Wu J, Zhang J, Jiang Z, Ma K. Towards the Antiviral Agents and Nanotechnology-Enabled Approaches Against Parvovirus B19. Front Cell Infect Microbiol 2022;12:916012. [DOI: 10.3389/fcimb.2022.916012] [Reference Citation Analysis]
27 Yasamineh S, Kalajahi HG, Yasamineh P, Gholizadeh O, Youshanlouei HR, Matloub SK, Mozafari M, Jokar E, Yazdani Y, Dadashpour M. Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19. Stem Cell Res Ther 2022;13:257. [PMID: 35715852 DOI: 10.1186/s13287-022-02944-7] [Reference Citation Analysis]
28 Azhdari MH, Goodarzi N, Doroudian M, MacLoughlin R. Molecular Insight into the Therapeutic Effects of Stem Cell-Derived Exosomes in Respiratory Diseases and the Potential for Pulmonary Delivery. Int J Mol Sci 2022;23:6273. [PMID: 35682948 DOI: 10.3390/ijms23116273] [Reference Citation Analysis]
29 Rezabakhsh A, Mahdipour M, Nourazarian A, Habibollahi P, Sokullu E, Avci ÇB, Rahbarghazi R. Application of exosomes for the alleviation of COVID-19-related pathologies. Cell Biochem Funct 2022. [PMID: 35647674 DOI: 10.1002/cbf.3720] [Reference Citation Analysis]
30 Zhu YG, Shi MM, Monsel A, Dai CX, Dong X, Shen H, Li SK, Chang J, Xu CL, Li P, Wang J, Shen MP, Ren CJ, Chen DC, Qu JM. Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study. Stem Cell Res Ther 2022;13:220. [PMID: 35619189 DOI: 10.1186/s13287-022-02900-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Wang Y, Zhang D, Jia M, Zheng X, Liu Y, Wang C, Lei F, Niu H, Chunhong L. ZIF-8 nanoparticles coated with macrophage-derived microvesicles for sustained, targeted delivery of dexamethasone to arthritic joints. J Drug Target 2022;:1-27. [PMID: 35549591 DOI: 10.1080/1061186X.2022.2077949] [Reference Citation Analysis]
32 Zargar MJ, Kaviani S, Vasei M, Soufi Zomorrod M, Heidari Keshel S, Soleimani M. Therapeutic role of mesenchymal stem cell-derived exosomes in respiratory disease. Stem Cell Res Ther 2022;13:194. [PMID: 35550188 DOI: 10.1186/s13287-022-02866-4] [Reference Citation Analysis]
33 Xie S, Zhang Q, Jiang L. Current Knowledge on Exosome Biogenesis, Cargo-Sorting Mechanism and Therapeutic Implications. Membranes 2022;12:498. [DOI: 10.3390/membranes12050498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Olga J, Regina H, Alena S, David P, Michaela L, Malinska HA, Jan M. Conventional and Nonconventional Sources of Exosomes–Isolation Methods and Influence on Their Downstream Biomedical Application. Front Mol Biosci 2022;9:846650. [DOI: 10.3389/fmolb.2022.846650] [Reference Citation Analysis]
35 Ting AE, Baker EK, Champagne J, Desai TJ, dos Santos CC, Heijink IH, Itescu S, Blanc KL, Matthay MA, Mcauley DF, Mcintyre L, Mei SH, Parekkadan B, Rocco PR, Sheridan J, Thébaud B, Weiss DJ. Proceedings of the ISCT scientific signature series symposium, “sdvances in cell and gene therapies for lung diseases and critical illnesses”. Cytotherapy 2022. [DOI: 10.1016/j.jcyt.2021.11.007] [Reference Citation Analysis]
36 Nguyen DD, Lai J. Synthesis, bioactive properties, and biomedical applications of intrinsically therapeutic nanoparticles for disease treatment. Chemical Engineering Journal 2022;435:134970. [DOI: 10.1016/j.cej.2022.134970] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
37 Liu S, Wu X, Chandra S, Lyon C, Ning B, jiang L, Fan J, Hu TY. Extracellular vesicles: emerging tools as therapeutic agent carriers. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.05.002] [Reference Citation Analysis]
38 Zoulikha M, Huang F, Wu Z, He W. COVID-19 inflammation and implications in drug delivery. J Control Release 2022;346:260-74. [PMID: 35469984 DOI: 10.1016/j.jconrel.2022.04.027] [Reference Citation Analysis]
39 Krishnan A, Muthusamy S, Fernandez FB, Kasoju N. Mesenchymal Stem Cell-Derived Extracellular Vesicles in the Management of COVID19-Associated Lung Injury: A Review on Publications, Clinical Trials and Patent Landscape. Tissue Eng Regen Med 2022. [PMID: 35384633 DOI: 10.1007/s13770-022-00441-9] [Reference Citation Analysis]
40 Wang S, Lei B, Zhang E, Gong P, Gu J, He L, Han L, Yuan Z. Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics. IJN 2022;Volume 17:1757-81. [DOI: 10.2147/ijn.s355366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Farhangnia P, Dehrouyeh S, Safdarian AR, Farahani SV, Gorgani M, Rezaei N, Akbarpour M, Delbandi A. Recent Advances in Passive Immunotherapies for COVID-19: The Evidence-Based Approaches and Clinical Trials. International Immunopharmacology 2022. [DOI: 10.1016/j.intimp.2022.108786] [Reference Citation Analysis]
42 Karyana M, Djaharuddin I, Rif'ati L, Arif M, Choi MK, Angginy N, Yoon A, Han J, Josh F, Arlinda D, Narulita A, Muchtar F, Bakri RA, Irmansyah S. Safety of DW-MSC infusion in patients with low clinical risk COVID-19 infection: a randomized, double-blind, placebo-controlled trial. Stem Cell Res Ther 2022;13:134. [PMID: 35365239 DOI: 10.1186/s13287-022-02812-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Chiang MD, Chang C, Shih H, Le VL, Huang Y, Huang C. Exosomes from Human Placenta Choriodecidual Membrane-Derived Mesenchymal Stem Cells Mitigate Endoplasmic Reticulum Stress, Inflammation, and Lung Injury in Lipopolysaccharide-Treated Obese Mice. Antioxidants 2022;11:615. [DOI: 10.3390/antiox11040615] [Reference Citation Analysis]
44 Ringdén O, Moll G, Gustafsson B, Sadeghi B. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome. Front Immunol 2022;13:839844. [DOI: 10.3389/fimmu.2022.839844] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
45 Zhou L, Kodidela S, Godse S, Thomas-gooch S, Kumar A, Raji B, Zhi K, Kochat H, Kumar S. Targeted Drug Delivery to the Central Nervous System Using Extracellular Vesicles. Pharmaceuticals 2022;15:358. [DOI: 10.3390/ph15030358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Xu R, Feng Z, Wang FS. Mesenchymal stem cell treatment for COVID-19. EBioMedicine 2022;77:103920. [PMID: 35279630 DOI: 10.1016/j.ebiom.2022.103920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Zimmermann CE, Mackens-Kiani L, Acil Y, Terheyden H. Characterization of porcine mesenchymal stromal cells and their proliferative and osteogenic potential in long-term culture. J Stem Cells Regen Med 2021;17:49-55. [PMID: 35250201 DOI: 10.46582/jsrm.1702008] [Reference Citation Analysis]
48 Fathi-Kazerooni M, Fattah-Ghazi S, Darzi M, Makarem J, Nasiri R, Salahshour F, Dehghan-Manshadi SA, Kazemnejad S. Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II. Stem Cell Res Ther 2022;13:96. [PMID: 35255966 DOI: 10.1186/s13287-022-02771-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Keshtkar S, Kaviani M, Soleimanian S, Azarpira N, Asvar Z, Pakbaz S. Stem Cell-Derived Exosome as Potential Therapeutics for Microbial Diseases. Front Microbiol 2021;12:786111. [PMID: 35237239 DOI: 10.3389/fmicb.2021.786111] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
50 Wu R, Fan X, Wang Y, Shen M, Zheng Y, Zhao S, Yang L. Mesenchymal Stem Cell-Derived Extracellular Vesicles in Liver Immunity and Therapy. Front Immunol 2022;13:833878. [DOI: 10.3389/fimmu.2022.833878] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Alagesan S, Brady J, Byrnes D, Fandiño J, Masterson C, Mccarthy S, Laffey J, O’toole D. Enhancement strategies for mesenchymal stem cells and related therapies. Stem Cell Res Ther 2022;13. [DOI: 10.1186/s13287-022-02747-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Chen L, Qu J, Kalyani FS, Zhang Q, Fan L, Fang Y, Li Y, Xiang C. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-021-04096-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Huang L, Rong Y, Tang X, Yi K, Qi P, Hou J, Liu W, He Y, Gao X, Yuan C, Wang F. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer. Mol Cancer 2022;21:45. [PMID: 35148751 DOI: 10.1186/s12943-022-01515-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
54 Zhao F, Ma Q, Yue Q, Chen H. SARS-CoV-2 Infection and Lung Regeneration. Clin Microbiol Rev 2022;:e0018821. [PMID: 35107300 DOI: 10.1128/cmr.00188-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Thomas SC, Kim JW, Pauletti GM, Hassett DJ, Kotagiri N. Exosomes: Biological Pharmaceutical Nanovectors for Theranostics. Front Bioeng Biotechnol 2021;9:808614. [PMID: 35096795 DOI: 10.3389/fbioe.2021.808614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
56 Najar M, Melki R, Khalife F, Lagneaux L, Bouhtit F, Moussa Agha D, Fahmi H, Lewalle P, Fayyad-Kazan M, Merimi M. Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization. Front Cell Dev Biol 2021;9:716853. [PMID: 35096805 DOI: 10.3389/fcell.2021.716853] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
57 Laurent A, Scaletta C, Abdel-sayed P, Michetti M, de Buys Roessingh A, Raffoul W, Hirt-burri N, Applegate LA. Biotechnology and Cytotherapeutics: The Swiss Progenitor-Cell Transplantation Program. Encyclopedia 2022;2:336-64. [DOI: 10.3390/encyclopedia2010021] [Reference Citation Analysis]
58 Karakaş N, Üçüncüoğlu S, Uludağ D, Karaoğlan BS, Shah K, Öztürk G. Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives. Cells 2022;11:465. [DOI: 10.3390/cells11030465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Paganelli A, Trubiani O, Diomede F, Pisciotta A, Paganelli R. Immunomodulating Profile of Dental Mesenchymal Stromal Cells: A Comprehensive Overview. Front Oral Health 2021;2:635055. [PMID: 35047993 DOI: 10.3389/froh.2021.635055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Wu X, Jin S, Ding C, Wang Y, He D, Liu Y. Mesenchymal Stem Cell-Derived Exosome Therapy of Microbial Diseases: From Bench to Bed. Front Microbiol 2021;12:804813. [PMID: 35046923 DOI: 10.3389/fmicb.2021.804813] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Hosseini NF, Dalirfardouei R, Aliramaei MR, Najafi R. Stem cells or their exosomes: which is preferred in COVID-19 treatment? Biotechnol Lett. [DOI: 10.1007/s10529-021-03209-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Babaei G, Zare N, Mihanfar A, Ansari MHK. Exosomes and COVID-19: challenges and opportunities. Comp Clin Path 2022;31:347-54. [PMID: 35039753 DOI: 10.1007/s00580-021-03311-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Hu W, Song X, Yu H, Sun J, Wang H, Zhao Y. Clinical Translational Potentials of Stem Cell-Derived Extracellular Vesicles in Type 1 Diabetes. Front Endocrinol 2022;12:682145. [DOI: 10.3389/fendo.2021.682145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 Islam KU, A-Elgadir TME, Afaq S, Ahmad T, Iqbal J. Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern. Front Pharmacol 2021;12:778219. [PMID: 35002711 DOI: 10.3389/fphar.2021.778219] [Reference Citation Analysis]
65 Li S, Zhu H, Zhao M, Liu W, Wang L, Zhu B, Xie W, Zhao C, Zhou Y, Ren C, Liu H, Jiang X. When stem cells meet COVID-19: recent advances, challenges and future perspectives. Stem Cell Res Ther 2022;13:9. [PMID: 35012650 DOI: 10.1186/s13287-021-02683-1] [Reference Citation Analysis]
66 Shan L, Liu S, Zhang Q, Zhou Q, Shang Y. Human bone marrow-mesenchymal stem cell-derived exosomal microRNA-188 reduces bronchial smooth muscle cell proliferation in asthma through suppressing the JARID2/Wnt/β-catenin axis. Cell Cycle 2022;:1-16. [PMID: 34974799 DOI: 10.1080/15384101.2021.2020432] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Kirkham AM, Monaghan M, Bailey AJ, Shorr R, Lalu MM, Fergusson DA, Allan DS. Mesenchymal stem/stromal cell-based therapies for COVID-19: First iteration of a living systematic review and meta-analysis. Cytotherapy 2022. [DOI: 10.1016/j.jcyt.2021.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
68 Luo Z, Sun Y, Qi B, Lin J, Chen Y, Xu Y, Chen J. Human bone marrow mesenchymal stem cell-derived extracellular vesicles inhibit shoulder stiffness via let-7a/Tgfbr1 axis. Bioactive Materials 2022. [DOI: 10.1016/j.bioactmat.2022.01.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
69 Dubey A, Lobo CL, Gs R, Shetty A, Hebbar S, El-zahaby SA. Exosomes: Emerging implementation of nanotechnology for detecting and managing novel corona virus- SARS-CoV-2. Asian Journal of Pharmaceutical Sciences 2022;17:20-34. [DOI: 10.1016/j.ajps.2021.08.004] [Reference Citation Analysis]
70 Phan TH, Kim SY, Rudge C, Chrzanowski W. Made by cells for cells - extracellular vesicles as next-generation mainstream medicines. J Cell Sci 2022;135:jcs259166. [PMID: 35019142 DOI: 10.1242/jcs.259166] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Ardalan M, Chodari L, Zununi Vahed S, Hosseiniyan Khatibi SM, Eftekhari A, Davaran S, Cucchiarini M, Roshangar L, Ahmadian E. Stem cell-derived biofactors fight against coronavirus infection. World J Stem Cells 2021; 13(12): 1813-1825 [DOI: 10.4252/wjsc.v13.i12.1813] [Reference Citation Analysis]
72 Shi L, Yuan X, Yao W, Wang S, Zhang C, Zhang B, Song J, Huang L, Xu Z, Fu JL, Li Y, Xu R, Li TT, Dong J, Cai J, Li G, Xie Y, Shi M, Li Y, Zhang Y, Xie WF, Wang FS. Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial. EBioMedicine 2021;75:103789. [PMID: 34963099 DOI: 10.1016/j.ebiom.2021.103789] [Reference Citation Analysis]
73 Pourgholaminejad A, Pahlavanneshan S, Basiri M. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges. Scand J Immunol 2021;:e13131. [PMID: 34936112 DOI: 10.1111/sji.13131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
74 Esquivel-Ruiz S, González-Rodríguez P, Lorente JA, Pérez-Vizcaíno F, Herrero R, Moreno L. Extracellular Vesicles and Alveolar Epithelial-Capillary Barrier Disruption in Acute Respiratory Distress Syndrome: Pathophysiological Role and Therapeutic Potential. Front Physiol 2021;12:752287. [PMID: 34887773 DOI: 10.3389/fphys.2021.752287] [Reference Citation Analysis]
75 Hamzagic AR, Miloradovic D, Miloradovic D, Ivosevic Z, Ljujic B. Mesenchymal Stem Cells Versus Covid-19. Can They Win the Battle? Serbian Journal of Experimental and Clinical Research 2021;0. [DOI: 10.2478/sjecr-2021-0024] [Reference Citation Analysis]
76 Santos A, Domingues C, Jarak I, Veiga F, Figueiras A. Osteosarcoma from the unknown to the use of exosomes as a versatile and dynamic therapeutic approach. Eur J Pharm Biopharm 2021:S0939-6411(21)00352-0. [PMID: 34896571 DOI: 10.1016/j.ejpb.2021.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Kuznik B, Khavinson V, Shapovalov K, Linkova N, Lukyanov S, Smolyakov Y, Tereshkov P, Shapovalov Y, Konnov V, Tsybikov N. Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients. Adv Gerontol 2021;11:368-76. [DOI: 10.1134/s2079057021040068] [Reference Citation Analysis]
78 da Silva KN, Pinheiro PCG, Gobatto ALN, Passos RDH, Paredes BD, França LSA, Nonaka CKV, Barreto-Duarte B, Araújo-Pereira M, Tibúrcio R, Cruz FF, Martins GLS, Andrade BB, de Castro-Faria-Neto HC, Rocco PRM, Souza BSF. Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibrosis: A Case Report. Front Med (Lausanne) 2021;8:767291. [PMID: 34869480 DOI: 10.3389/fmed.2021.767291] [Reference Citation Analysis]
79 Warrier S, Mohana Sundaram S, Varier L, Balasubramanian A. Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19? Placenta 2021;117:161-8. [PMID: 34915433 DOI: 10.1016/j.placenta.2021.12.005] [Reference Citation Analysis]
80 You J, Fu Z, Zou L. Mechanism and Potential of Extracellular Vesicles Derived From Mesenchymal Stem Cells for the Treatment of Infectious Diseases. Front Microbiol 2021;12:761338. [PMID: 34764947 DOI: 10.3389/fmicb.2021.761338] [Reference Citation Analysis]
81 Wang MY, Zhou TY, Zhang ZD, Liu HY, Zheng ZY, Xie HQ. Current therapeutic strategies for respiratory diseases using mesenchymal stem cells. MedComm (2020) 2021;2:351-80. [PMID: 34766151 DOI: 10.1002/mco2.74] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Zanirati G, Provenzi L, Libermann LL, Bizotto SC, Ghilardi IM, Marinowic DR, Shetty AK, Da Costa JC. Stem cell-based therapy for COVID-19 and ARDS: a systematic review. NPJ Regen Med 2021;6:73. [PMID: 34750382 DOI: 10.1038/s41536-021-00181-9] [Reference Citation Analysis]
83 Li C, Zhao H, Cheng L, Wang B. Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice. Cell Biosci 2021;11:187. [PMID: 34727974 DOI: 10.1186/s13578-021-00698-y] [Reference Citation Analysis]
84 Pal D, Goyal J, Sharma U, Sharma A, Prashar S, Rathi G, Sharma B, Kumar U. Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope. Life Sci 2021;284:119901. [PMID: 34453941 DOI: 10.1016/j.lfs.2021.119901] [Reference Citation Analysis]
85 Bhalerao A, Raut S, Noorani B, Mancuso S, Cucullo L. Molecular Mechanisms of Multi-Organ Failure in COVID-19 and Potential of Stem Cell Therapy. Cells 2021;10:2878. [PMID: 34831101 DOI: 10.3390/cells10112878] [Reference Citation Analysis]
86 Miao J, Ren Z, Zhong Z, Yan L, Xia X, Wang J, Yang J. Mesenchymal Stem Cells: Potential Therapeutic Prospect of Paracrine Pathways in Neonatal Infection. J Interferon Cytokine Res 2021;41:365-74. [PMID: 34672801 DOI: 10.1089/jir.2021.0094] [Reference Citation Analysis]
87 Low SS, Lim CN, Yew M, Chai WS, Low LE, Manickam S, Tey BT, Show PL. Recent ultrasound advancements for the manipulation of nanobiomaterials and nanoformulations for drug delivery. Ultrason Sonochem 2021;80:105805. [PMID: 34706321 DOI: 10.1016/j.ultsonch.2021.105805] [Reference Citation Analysis]
88 Xu Z, Huang Y, Zhou J, Deng X, He W, Liu X, Li Y, Zhong N, Sang L. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS. Front Immunol 2021;12:738697. [PMID: 34659231 DOI: 10.3389/fimmu.2021.738697] [Reference Citation Analysis]
89 Gupta SK, Srivastava M, Minocha R, Akash A, Dangwal S, Dandekar T. Alveolar Regeneration in COVID-19 Patients: A Network Perspective. Int J Mol Sci 2021;22:11279. [PMID: 34681944 DOI: 10.3390/ijms222011279] [Reference Citation Analysis]
90 Infante A, Rodríguez CI. Cell and Cell-Free Therapies to Counteract Human Premature and Physiological Aging: MSCs Come to Light. J Pers Med 2021;11:1043. [PMID: 34683184 DOI: 10.3390/jpm11101043] [Reference Citation Analysis]
91 Liu WY, Chien CW, Tung TH. Healthcare practice strategies for integrating personalized medicine: Management of COVID-19. World J Clin Cases 2021; 9(29): 8647-8657 [PMID: 34734043 DOI: 10.12998/wjcc.v9.i29.8647] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Lu Q, Huang S, Meng X, Zhang J, Yu S, Li J, Shi M, Fan H, Zhao Y. Mechanism of Phosgene-Induced Acute Lung Injury and Treatment Strategy. Int J Mol Sci 2021;22:10933. [PMID: 34681591 DOI: 10.3390/ijms222010933] [Reference Citation Analysis]
93 Ghaffari S, Kazerooni H, Salehi-Najafabadi A. An overview of the recent findings of cell-based therapies for the treatment and management of COVID-19. Int Immunopharmacol 2021;101:108226. [PMID: 34634685 DOI: 10.1016/j.intimp.2021.108226] [Reference Citation Analysis]
94 Sanwlani R, Gangoda L. Role of Extracellular Vesicles in Cell Death and Inflammation. Cells 2021;10:2663. [PMID: 34685643 DOI: 10.3390/cells10102663] [Reference Citation Analysis]
95 Dubey A, Lobo CL, Gs R, Shetty A, Hebbar S, El-Zahaby SA. Exosomes: Emerging Implementation of Nanotechnology for Detecting and Managing Novel Corona Virus- SARS-CoV-2. Asian J Pharm Sci 2021. [PMID: 34630723 DOI: 10.1016/j.ajps.2021.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Ligotti ME, Pojero F, Accardi G, Aiello A, Caruso C, Duro G, Candore G. Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation? Front Cell Dev Biol 2021;9:725606. [PMID: 34595175 DOI: 10.3389/fcell.2021.725606] [Reference Citation Analysis]
97 Karn V, Ahmed S, Tsai LW, Dubey R, Ojha S, Singh HN, Kumar M, Gupta PK, Sadhu S, Jha NK, Kumar A, Pandit S, Kumar S. Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects. Biomedicines 2021;9:1373. [PMID: 34680490 DOI: 10.3390/biomedicines9101373] [Reference Citation Analysis]
98 Wang J, Shi P, Chen D, Wang S, Wang P, Feng X, Zhang L. Research Status of the Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of COVID-19-Related Pneumonia: A Systematic Review and Meta-Analysis. Stem Cells Dev 2021;30:947-69. [PMID: 34416823 DOI: 10.1089/scd.2021.0179] [Reference Citation Analysis]
99 Staubach S, Bauer FN, Tertel T, Börger V, Stambouli O, Salzig D, Giebel B. Scaled preparation of extracellular vesicles from conditioned media. Adv Drug Deliv Rev 2021;177:113940. [PMID: 34419502 DOI: 10.1016/j.addr.2021.113940] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
100 Qiao Q, Liu X, Yang T, Cui K, Kong L, Yang C, Zhang Z. Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design. Acta Pharm Sin B 2021;11:3060-91. [PMID: 33977080 DOI: 10.1016/j.apsb.2021.04.023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
101 Beghini DG, Horita SI, Henriques-Pons A. Mesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future. Cells 2021;10:2588. [PMID: 34685567 DOI: 10.3390/cells10102588] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Abu-El-Rub E, Khasawneh RR, Almahasneh F, Altaany Z, Bataineh N, Zegallai H, Sekaran S. Mesenchymal stem cells and COVID-19: What they do and what they can do. World J Stem Cells 2021; 13(9): 1318-1337 [PMID: 34630865 DOI: 10.4252/wjsc.v13.i9.1318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Laurent A, Abdel-Sayed P, Hirt-Burri N, Scaletta C, Michetti M, de Buys Roessingh A, Raffoul W, Applegate LA. Evolution of Diploid Progenitor Lung Cell Applications: From Optimized Biotechnological Substrates to Potential Active Pharmaceutical Ingredients in Respiratory Tract Regenerative Medicine. Cells 2021;10:2526. [PMID: 34685505 DOI: 10.3390/cells10102526] [Reference Citation Analysis]
104 Rafiee Z, Nejaddehbashi F, Nasrolahi A, Khademi Moghadam F. Stem cell-based and mesenchymal stem cell derivatives for coronavirus treatment. Biotechnol Appl Biochem 2021. [PMID: 34555225 DOI: 10.1002/bab.2259] [Reference Citation Analysis]
105 Shi L, Wang L, Xu R, Zhang C, Xie Y, Liu K, Li T, Hu W, Zhen C, Wang FS. Mesenchymal stem cell therapy for severe COVID-19. Signal Transduct Target Ther 2021;6:339. [PMID: 34497264 DOI: 10.1038/s41392-021-00754-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Merimi M, El-Majzoub R, Lagneaux L, Moussa Agha D, Bouhtit F, Meuleman N, Fahmi H, Lewalle P, Fayyad-Kazan M, Najar M. The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings. Front Cell Dev Biol 2021;9:661532. [PMID: 34490235 DOI: 10.3389/fcell.2021.661532] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
107 Keane C, Coalter M, Martin-Loeches I. Immune System Disequilibrium-Neutrophils, Their Extracellular Traps, and COVID-19-Induced Sepsis. Front Med (Lausanne) 2021;8:711397. [PMID: 34485339 DOI: 10.3389/fmed.2021.711397] [Reference Citation Analysis]
108 Saad MH, Badierah R, Redwan EM, El-Fakharany EM. A Comprehensive Insight into the Role of Exosomes in Viral Infection: Dual Faces Bearing Different Functions. Pharmaceutics 2021;13:1405. [PMID: 34575480 DOI: 10.3390/pharmaceutics13091405] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
109 Alanazi A. COVID-19 and the role of stem cells. Regen Ther 2021;18:334-8. [PMID: 34462723 DOI: 10.1016/j.reth.2021.08.008] [Reference Citation Analysis]
110 Jung AL, Schmeck B, Wiegand M, Bedenbender K, Benedikter BJ. The clinical role of host and bacterial-derived extracellular vesicles in pneumonia. Adv Drug Deliv Rev 2021;176:113811. [PMID: 34022269 DOI: 10.1016/j.addr.2021.05.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
111 Kiaie N, Ghanavati SPM, Miremadi SS, Hadipour A, Aghdam RM. Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Therapy, Preclinical and Clinical Evidence. Int J Stem Cells 2021;14:252-61. [PMID: 34158414 DOI: 10.15283/ijsc20182] [Reference Citation Analysis]
112 Shi MM, Yang QY, Monsel A, Yan JY, Dai CX, Zhao JY, Shi GC, Zhou M, Zhu XM, Li SK, Li P, Wang J, Li M, Lei JG, Xu D, Zhu YG, Qu JM. Preclinical efficacy and clinical safety of clinical-grade nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles. J Extracell Vesicles 2021;10:e12134. [PMID: 34429860 DOI: 10.1002/jev2.12134] [Reference Citation Analysis]
113 Foo JB, Looi QH, Chong PP, Hassan NH, Yeo GEC, Ng CY, Koh B, How CW, Lee SH, Law JX. Comparing the Therapeutic Potential of Stem Cells and their Secretory Products in Regenerative Medicine. Stem Cells Int 2021;2021:2616807. [PMID: 34422061 DOI: 10.1155/2021/2616807] [Reference Citation Analysis]
114 Abdelgawad M, Bakry NS, Farghali AA, Abdel-Latif A, Lotfy A. Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects. Stem Cell Res Ther 2021;12:469. [PMID: 34419143 DOI: 10.1186/s13287-021-02542-z] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
115 Mosquera-Heredia MI, Morales LC, Vidal OM, Barceló E, Silvera-Redondo C, Vélez JI, Garavito-Galofre P. Exosomes: Potential Disease Biomarkers and New Therapeutic Targets. Biomedicines 2021;9:1061. [PMID: 34440265 DOI: 10.3390/biomedicines9081061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Sütlüoğlu H, Özdemir Ö. May mesenchymal stem cell transplantation be a solution for COVID-19 induced cytokine storm? World J Transplant 2021; 11(8): 344-355 [PMID: 34447671 DOI: 10.5500/wjt.v11.i8.344] [Reference Citation Analysis]
117 Yousefi Dehbidi M, Goodarzi N, Azhdari MH, Doroudian M. Mesenchymal stem cells and their derived exosomes to combat Covid-19. Rev Med Virol 2021;:e2281. [PMID: 34363275 DOI: 10.1002/rmv.2281] [Reference Citation Analysis]
118 Panda B, Sharma Y, Gupta S, Mohanty S. Mesenchymal Stem Cell-Derived Exosomes as an Emerging Paradigm for Regenerative Therapy and Nano-Medicine: A Comprehensive Review. Life (Basel) 2021;11:784. [PMID: 34440528 DOI: 10.3390/life11080784] [Reference Citation Analysis]
119 Xie Y, Chen F, Jia L, Chen R, Zhang VW, Zhong X, Wang D. Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia-induced bronchopulmonary dysplasia in rats. J Cell Mol Med 2021;25:8558-66. [PMID: 34322990 DOI: 10.1111/jcmm.16817] [Reference Citation Analysis]
120 Alberro A, Iparraguirre L, Fernandes A, Otaegui D. Extracellular Vesicles in Blood: Sources, Effects, and Applications. Int J Mol Sci 2021;22:8163. [PMID: 34360924 DOI: 10.3390/ijms22158163] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
121 Gurunathan S, Kang MH, Kim JH. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments. Front Immunol 2021;12:716407. [PMID: 34394121 DOI: 10.3389/fimmu.2021.716407] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
122 Lin S, Chen Q, Zhang L, Ge S, Luo Y, He W, Xu C, Zeng M. Overexpression of HOXB4 Promotes Protection of Bone Marrow Mesenchymal Stem Cells Against Lipopolysaccharide-Induced Acute Lung Injury Partially Through the Activation of Wnt/β-Catenin Signaling. J Inflamm Res 2021;14:3637-49. [PMID: 34349541 DOI: 10.2147/JIR.S319416] [Reference Citation Analysis]
123 da Silva KN, Gobatto ALN, Costa-Ferro ZSM, Cavalcante BRR, Caria ACI, de Aragão França LS, Nonaka CKV, de Macêdo Lima F, Lopes-Pacheco M, Rocco PRM, de Freitas Souza BS. Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19? Stem Cell Res Ther 2021;12:425. [PMID: 34315546 DOI: 10.1186/s13287-021-02502-7] [Reference Citation Analysis]
124 Fernández-Francos S, Eiro N, González-Galiano N, Vizoso FJ. Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives. Int J Mol Sci 2021;22:7850. [PMID: 34360616 DOI: 10.3390/ijms22157850] [Reference Citation Analysis]
125 Yan YY, Zhou WM, Wang YQ, Guo QR, Zhao FX, Zhu ZY, Xing YX, Zhang HY, Aljofan M, Jarrahi AM, Makabel B, Zhang JY. The Potential Role of Extracellular Vesicles in COVID-19 Treatment: Opportunity and Challenge. Front Mol Biosci 2021;8:699929. [PMID: 34368228 DOI: 10.3389/fmolb.2021.699929] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Safari A, Lionetti V, Razeghian-Jahromi I. Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction. Stem Cell Res Ther 2021;12:404. [PMID: 34266486 DOI: 10.1186/s13287-021-02482-8] [Reference Citation Analysis]
127 Bokharee N, Khan YH, Khokhar A, Mallhi TH, Alotaibi NH, Rasheed M. Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials. Expert Rev Anti Infect Ther 2021;:1-26. [PMID: 33719819 DOI: 10.1080/14787210.2021.1902805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Moghadasi S, Elveny M, Rahman HS, Suksatan W, Jalil AT, Abdelbasset WK, Yumashev AV, Shariatzadeh S, Motavalli R, Behzad F, Marofi F, Hassanzadeh A, Pathak Y, Jarahian M. A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine. J Transl Med 2021;19:302. [PMID: 34253242 DOI: 10.1186/s12967-021-02980-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
129 Khanh VC, Fukushige M, Chang YH, Hoang NN, Yamashita T, Obata-Yasuoka M, Hamada H, Osaka M, Hiramatsu Y, Ohneda O. Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions. Stem Cells Dev 2021;30:758-72. [PMID: 34074129 DOI: 10.1089/scd.2021.0065] [Reference Citation Analysis]
130 Sharma D, Zhao F. Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19. NPJ Regen Med 2021;6:37. [PMID: 34193864 DOI: 10.1038/s41536-021-00147-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Feng G, Shi L, Huang T, Ji N, Zheng Y, Lin H, Niu C, Wang Y, Li R, Huang M, Chen X, Shu L, Wu M, Deng K, Wei J, Wang X, Cao Y, Yan J. Human Umbilical Cord Mesenchymal Stromal Cell Treatment of Severe COVID-19 Patients: A 3-Month Follow-Up Study Following Hospital Discharge. Stem Cells Dev 2021;30:773-81. [PMID: 34044609 DOI: 10.1089/scd.2021.0015] [Reference Citation Analysis]
132 Zani-Ruttenstock E, Antounians L, Khalaj K, Figueira RL, Zani A. The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19. Eur J Pediatr Surg 2021;31:326-34. [PMID: 34161984 DOI: 10.1055/s-0041-1731294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
133 Becerra J, Duran I. Inflammation, a common mechanism in frailty and COVID19, and stem cells as a therapeutic approach. Stem Cells Transl Med 2021. [PMID: 34164948 DOI: 10.1002/sctm.21-0074] [Reference Citation Analysis]
134 Liu X, Gao C, Wang Y, Niu L, Jiang S, Pan S. BMSC-Derived Exosomes Ameliorate LPS-Induced Acute Lung Injury by miR-384-5p-Controlled Alveolar Macrophage Autophagy. Oxid Med Cell Longev 2021;2021:9973457. [PMID: 34234888 DOI: 10.1155/2021/9973457] [Reference Citation Analysis]
135 Dilogo IH, Aditianingsih D, Sugiarto A, Burhan E, Damayanti T, Sitompul PA, Mariana N, Antarianto RD, Liem IK, Kispa T, Mujadid F, Novialdi N, Luviah E, Kurniawati T, Lubis AMT, Rahmatika D. Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial. Stem Cells Transl Med 2021. [PMID: 34102020 DOI: 10.1002/sctm.21-0046] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
136 Kaffash Farkhad N, Reihani H, Sedaghat A, Moghadam AA, Moghadam AB, Tavakol-Afshari J. Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies. Regen Ther 2021;18:152-60. [PMID: 34124322 DOI: 10.1016/j.reth.2021.05.007] [Reference Citation Analysis]
137 Sang L, Guo X, Shi J, Hou S, Fan H, Lv Q. Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update. Stem Cells Int 2021;2021:5593584. [PMID: 34211556 DOI: 10.1155/2021/5593584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Georgescu A, Simionescu M. Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis. Int J Mol Sci 2021;22:5967. [PMID: 34073119 DOI: 10.3390/ijms22115967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
139 Mazini L, Rochette L, Malka G. Exosomes contribution in COVID-19 patients' treatment. J Transl Med 2021;19:234. [PMID: 34059065 DOI: 10.1186/s12967-021-02884-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Gupta A, Shivaji K, Kadam S, Gupta M, Rodriguez HC, Potty AG, El-Amin SF 3rd, Maffulli N. Immunomodulatory extracellular vesicles: an alternative to cell therapy for COVID-19. Expert Opin Biol Ther 2021;:1-10. [PMID: 33886388 DOI: 10.1080/14712598.2021.1921141] [Reference Citation Analysis]
141 Iovino L, Thur LA, Gnjatic S, Chapuis A, Milano F, Hill JA. Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy. J Immunother Cancer 2021;9:e002392. [PMID: 33986127 DOI: 10.1136/jitc-2021-002392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
142 Hassanzadeh A, Rahman HS, Markov A, Endjun JJ, Zekiy AO, Chartrand MS, Beheshtkhoo N, Kouhbanani MAJ, Marofi F, Nikoo M, Jarahian M. Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities. Stem Cell Res Ther 2021;12:297. [PMID: 34020704 DOI: 10.1186/s13287-021-02378-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
143 Cai Q, Yin F, Hao L, Jiang W. Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19. Stem Cells Dev 2021;30:459-72. [PMID: 33715385 DOI: 10.1089/scd.2020.0198] [Reference Citation Analysis]
144 Wei F, Kong D, Li T, Li A, Tan Y, Fang J, Zhuang X, Lai C, Xu W, Dong H, Ma C, Hong K, Cui Y, Tang S, Yu F, Zheng C. Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19. Clinics (Sao Paulo) 2021;76:e2604. [PMID: 34008772 DOI: 10.6061/clinics/2021/e2604] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Rahimi Pordanjani S, Hasanpour A, Askarpour H, Bastam D, Rafiee M, Khazaei Z, Mazaheri E, Vaziri MH, Sabour S. Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of COVID-19 Pandemic: A Narrative Review. Int J Prev Med 2021;12:38. [PMID: 34249287 DOI: 10.4103/ijpvm.IJPVM_469_20] [Reference Citation Analysis]
146 Anand K, Vadivalagan C, Joseph JS, Singh SK, Gulati M, Shahbaaz M, Abdellattif MH, Prasher P, Gupta G, Chellappan DK, Dua K. A novel nano therapeutic using convalescent plasma derived exosomal (CPExo) for COVID-19: A combined hyperactive immune modulation and diagnostics. Chem Biol Interact 2021;344:109497. [PMID: 33991505 DOI: 10.1016/j.cbi.2021.109497] [Reference Citation Analysis]
147 Singh B, Mal G, Verma V, Tiwari R, Khan MI, Mohapatra RK, Mitra S, Alyami SA, Emran TB, Dhama K, Moni MA. Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era. Stem Cell Res Ther 2021;12:283. [PMID: 33980321 DOI: 10.1186/s13287-021-02334-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Su Y, Guo H, Liu Q. Effects of mesenchymal stromal cell-derived extracellular vesicles in acute respiratory distress syndrome (ARDS): Current understanding and future perspectives. J Leukoc Biol 2021;110:27-38. [PMID: 33955590 DOI: 10.1002/JLB.3MR0321-545RR] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
149 Afarid M, Sanie-Jahromi F. Mesenchymal Stem Cells and COVID-19: Cure, Prevention, and Vaccination. Stem Cells Int 2021;2021:6666370. [PMID: 34035820 DOI: 10.1155/2021/6666370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Zeng C, Hou X, Bohmer M, Dong Y. Advances of nanomaterials-based strategies for fighting against COVID-19. View (Beijing) 2021;:20200180. [PMID: 34766161 DOI: 10.1002/VIW.20200180] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Xia X, Yuan P, Liu Y, Wang Y, Cao W, Zheng JC. Emerging roles of extracellular vesicles in COVID-19, a double-edged sword? Immunology 2021;163:416-30. [PMID: 33742451 DOI: 10.1111/imm.13329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
152 Carvalho JL, Silva-Carvalho AE, Garcez EM, Saldanha-Araujo F. Commentary: Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment. Front Immunol 2021;12:682195. [PMID: 33995424 DOI: 10.3389/fimmu.2021.682195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
153 Bailey AJM, Li H, Kirkham AM, Tieu A, Maganti HB, Shorr R, Fergusson DA, Lalu MM, Elomazzen H, Allan DS. MSC-Derived Extracellular Vesicles to Heal Diabetic Wounds: a Systematic Review and Meta-Analysis of Preclinical Animal Studies. Stem Cell Rev Rep 2021. [PMID: 33893619 DOI: 10.1007/s12015-021-10164-4] [Reference Citation Analysis]
154 Çetin Z. Targeting the PANoptosome with miRNA Loaded Mesenchymal Stem Cell Derived Extracellular Vesicles; a New Path to Fight Against the Covid-19? Stem Cell Rev Rep 2021;17:1074-7. [PMID: 33851324 DOI: 10.1007/s12015-021-10166-2] [Reference Citation Analysis]
155 Gimona M, Brizzi MF, Choo ABH, Dominici M, Davidson SM, Grillari J, Hermann DM, Hill AF, de Kleijn D, Lai RC, Lai CP, Lim R, Monguió-Tortajada M, Muraca M, Ochiya T, Ortiz LA, Toh WS, Yi YW, Witwer KW, Giebel B, Lim SK. Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles. Cytotherapy 2021;23:373-80. [PMID: 33934807 DOI: 10.1016/j.jcyt.2021.01.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
156 Zheng Q, Zhang S, Guo WZ, Li XK. The Unique Immunomodulatory Properties of MSC-Derived Exosomes in Organ Transplantation. Front Immunol 2021;12:659621. [PMID: 33889158 DOI: 10.3389/fimmu.2021.659621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Muthu S, Bapat A, Jain R, Jeyaraman N, Jeyaraman M. Exosomal therapy-a new frontier in regenerative medicine. Stem Cell Investig 2021;8:7. [PMID: 33969112 DOI: 10.21037/sci-2020-037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
158 Gentile P. SARS-CoV-2: the "Uncensored" Truth about Its Origin and Adipose-Derived Mesenchymal Stem Cells as New Potential Immune-Modulatory Weapon. Aging Dis 2021;12:330-44. [PMID: 33815867 DOI: 10.14336/AD.2021.0121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
159 Harrell CR, Popovska Jovicic B, Djonov V, Volarevic V. Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Treatment of Viral Diseases. Pathogens 2021;10:409. [PMID: 33915728 DOI: 10.3390/pathogens10040409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
160 Bogatcheva NV, Coleman ME. Concentrated Secretome of Adipose Stromal Cells Limits Influenza A Virus-Induced Lung Injury in Mice. Cells 2021;10:720. [PMID: 33804896 DOI: 10.3390/cells10040720] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Najafi-Ghalehlou N, Roudkenar MH, Langerodi HZ, Roushandeh AM. Taming of Covid-19: potential and emerging application of mesenchymal stem cells. Cytotechnology 2021;:1-46. [PMID: 33776206 DOI: 10.1007/s10616-021-00461-8] [Reference Citation Analysis]
162 Markov A, Thangavelu L, Aravindhan S, Zekiy AO, Jarahian M, Chartrand MS, Pathak Y, Marofi F, Shamlou S, Hassanzadeh A. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell Res Ther 2021;12:192. [PMID: 33736695 DOI: 10.1186/s13287-021-02265-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
163 Xiong J, Chen L, Zhang L, Bao L, Shi Y. Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Severe COVID-19. Cell Transplant 2021;30:963689721995455. [PMID: 33650894 DOI: 10.1177/0963689721995455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
164 Lou S, Duan Y, Nie H, Cui X, Du J, Yao Y. Mesenchymal stem cells: Biological characteristics and application in disease therapy. Biochimie 2021;185:9-21. [PMID: 33711361 DOI: 10.1016/j.biochi.2021.03.003] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
165 Raghav A, Khan ZA, Upadhayay VK, Tripathi P, Gautam KA, Mishra BK, Ahmad J, Jeong GB. Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients. Cells 2021;10:587. [PMID: 33799966 DOI: 10.3390/cells10030587] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
166 Pinky, Gupta S, Krishnakumar V, Sharma Y, Dinda AK, Mohanty S. Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19. Stem Cell Rev Rep 2021;17:33-43. [PMID: 32661867 DOI: 10.1007/s12015-020-10002-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 33] [Article Influence: 23.0] [Reference Citation Analysis]
167 Park YJ, Farooq J, Cho J, Sadanandan N, Cozene B, Gonzales-Portillo B, Saft M, Borlongan MC, Borlongan MC, Shytle RD, Willing AE, Garbuzova-Davis S, Sanberg PR, Borlongan CV. Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics. Stem Cell Rev Rep 2021;17:9-32. [PMID: 32789802 DOI: 10.1007/s12015-020-10026-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
168 Rong Y, Zhang J, Jiang D, Ji C, Liu W, Wang J, Ge X, Tang P, Yu S, Cui W, Cai W. Hypoxic pretreatment of small extracellular vesicles mediates cartilage repair in osteoarthritis by delivering miR-216a-5p. Acta Biomater 2021;122:325-42. [PMID: 33348062 DOI: 10.1016/j.actbio.2020.12.034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
169 Riedel RN, Pérez-Pérez A, Sánchez-Margalet V, Varone CL, Maymó JL. Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus? Stem Cell Res Ther 2021;12:155. [PMID: 33648582 DOI: 10.1186/s13287-021-02216-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
170 Chen MR, Kuo HC, Lee YJ, Chi H, Li SC, Lee HC, Yang KD. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children. Front Immunol 2021;12:632890. [PMID: 33732254 DOI: 10.3389/fimmu.2021.632890] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
171 Abreu SC, Lopes-Pacheco M, Weiss DJ, Rocco PRM. Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Perspectives. Front Cell Dev Biol 2021;9:600711. [PMID: 33659247 DOI: 10.3389/fcell.2021.600711] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
172 Gobin J, Muradia G, Mehic J, Westwood C, Couvrette L, Stalker A, Bigelow S, Luebbert CC, Bissonnette FS, Johnston MJW, Sauvé S, Tam RY, Wang L, Rosu-Myles M, Lavoie JR. Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell. Stem Cell Res Ther 2021;12:127. [PMID: 33579358 DOI: 10.1186/s13287-021-02190-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
173 Beitia M, Delgado D, Sánchez P, Vallejo de la Cueva A, Cugat JR, Sánchez M. Platelet Lysate Nebulization Protocol for the Treatment of COVID-19 and Its Sequels: Proof of Concept and Scientific Rationale. Int J Mol Sci 2021;22:1856. [PMID: 33673372 DOI: 10.3390/ijms22041856] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
174 Lee BC, Kang I, Yu KR. Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes. J Clin Med 2021;10:711. [PMID: 33670202 DOI: 10.3390/jcm10040711] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
175 Samara A, Herlenius E. Is There an Effect of Fetal Mesenchymal Stem Cells in the Mother-Fetus Dyad in COVID-19 Pregnancies and Vertical Transmission? Front Physiol 2020;11:624625. [PMID: 33679426 DOI: 10.3389/fphys.2020.624625] [Reference Citation Analysis]
176 Musial C, Gorska-Ponikowska M. Medical progress: Stem cells as a new therapeutic strategy for COVID-19. Stem Cell Res 2021;52:102239. [PMID: 33601098 DOI: 10.1016/j.scr.2021.102239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
177 Pironti G, Andersson DC, Lund LH. Mechanistic and Therapeutic Implications of Extracellular Vesicles as a Potential Link Between Covid-19 and Cardiovascular Disease Manifestations. Front Cell Dev Biol 2021;9:640723. [PMID: 33644077 DOI: 10.3389/fcell.2021.640723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
178 Fröhlich E. Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases-Intravenous Administration versus Inhalation. Pharmaceutics 2021;13:232. [PMID: 33562240 DOI: 10.3390/pharmaceutics13020232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
179 Dabrowska S, Andrzejewska A, Janowski M, Lukomska B. Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Outlook for Inflammatory and Degenerative Diseases. Front Immunol 2020;11:591065. [PMID: 33613514 DOI: 10.3389/fimmu.2020.591065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
180 Croci S, Bonacini M, Dolci G, Massari M, Facciolongo N, Pignatti E, Pisciotta A, Carnevale G, Negro A, Cassone G, Muratore F, Belloni L, Zerbini A, Salvarani C. Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients. Front Cell Dev Biol 2020;8:609204. [PMID: 33634100 DOI: 10.3389/fcell.2020.609204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
181 Machhi J, Shahjin F, Das S, Patel M, Abdelmoaty MM, Cohen JD, Singh PA, Baldi A, Bajwa N, Kumar R, Vora LK, Patel TA, Oleynikov MD, Soni D, Yeapuri P, Mukadam I, Chakraborty R, Saksena CG, Herskovitz J, Hasan M, Oupicky D, Das S, Donnelly RF, Hettie KS, Chang L, Gendelman HE, Kevadiya BD. A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention. J Neuroimmune Pharmacol 2021;16:270-88. [PMID: 33544324 DOI: 10.1007/s11481-020-09981-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
182 Khoury M, Ikonomou L, Dominici M, LeBlanc K, Levine BL, Weiss DJ. The Coronavirus Pandemic: A Pitfall or a Fast Track for Validating Cell Therapy Products? Stem Cells Dev 2021;30:119-27. [PMID: 33307968 DOI: 10.1089/scd.2020.0122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
183 Rios CI, Cassatt DR, Hollingsworth BA, Satyamitra MM, Tadesse YS, Taliaferro LP, Winters TA, DiCarlo AL. Commonalities Between COVID-19 and Radiation Injury. Radiat Res 2021;195:1-24. [PMID: 33064832 DOI: 10.1667/RADE-20-00188.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
184 Hashemian SR, Aliannejad R, Zarrabi M, Soleimani M, Vosough M, Hosseini SE, Hossieni H, Keshel SH, Naderpour Z, Hajizadeh-Saffar E, Shajareh E, Jamaati H, Soufi-Zomorrod M, Khavandgar N, Alemi H, Karimi A, Pak N, Rouzbahani NH, Nouri M, Sorouri M, Kashani L, Madani H, Aghdami N, Vasei M, Baharvand H. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series. Stem Cell Res Ther 2021;12:91. [PMID: 33514427 DOI: 10.1186/s13287-021-02165-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 21.0] [Reference Citation Analysis]
185 Gholizadeh-Ghaleh Aziz S, Alipour S, Ranjbarvan P, Azari A, Babaei G, Golchin A. Critical roles of TLRs on the polarization of mesenchymal stem cells for cell therapy of viral infections: a notice for COVID-19 treatment. Comp Clin Path 2021;:1-10. [PMID: 33551714 DOI: 10.1007/s00580-021-03209-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
186 Mahendiratta S, Bansal S, Sarma P, Kumar H, Choudhary G, Kumar S, Prakash A, Sehgal R, Medhi B. Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review. Biomed Pharmacother. 2021;137:111300. [PMID: 33529945 DOI: 10.1016/j.biopha.2021.111300] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
187 Schultz IC, Bertoni APS, Wink MR. Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis. Stem Cell Rev Rep 2021;17:341-56. [PMID: 33511519 DOI: 10.1007/s12015-021-10122-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
188 Lopes-Pacheco M, Silva PL, Cruz FF, Battaglini D, Robba C, Pelosi P, Morales MM, Caruso Neves C, Rocco PRM. Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies. Front Physiol 2021;12:593223. [PMID: 33584343 DOI: 10.3389/fphys.2021.593223] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
189 Sabanovic B, Piva F, Cecati M, Giulietti M. Promising Extracellular Vesicle-Based Vaccines against Viruses, Including SARS-CoV-2. Biology (Basel) 2021;10:94. [PMID: 33513850 DOI: 10.3390/biology10020094] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
190 Kaspi H, Semo J, Abramov N, Dekel C, Lindborg S, Kern R, Lebovits C, Aricha R. MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model. Stem Cell Res Ther 2021;12:72. [PMID: 33468250 DOI: 10.1186/s13287-021-02143-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
191 Tang Y, Zhou Y, Li HJ. Advances in mesenchymal stem cell exosomes: a review. Stem Cell Res Ther 2021;12:71. [PMID: 33468232 DOI: 10.1186/s13287-021-02138-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
192 Lutz H, Popowski KD, Dinh PC, Cheng K. Advanced Nanobiomedical Approaches to Combat Coronavirus Disease of 2019. Adv Nanobiomed Res 2021;:2000063. [PMID: 33681865 DOI: 10.1002/anbr.202000063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Ghaffari M, Mollazadeh-Bajestani M, Moztarzadeh F, Uludağ H, Hardy JG, Mozafari M. An overview of the use of biomaterials, nanotechnology, and stem cells for detection and treatment of COVID-19: towards a framework to address future global pandemics. Emergent Mater 2021;:1-16. [PMID: 33426467 DOI: 10.1007/s42247-020-00143-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
194 Wang SH, Shetty AK, Jin K, Chunhua Zhao R. Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges. Front Cell Dev Biol 2020;8:627414. [PMID: 33469541 DOI: 10.3389/fcell.2020.627414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
195 Barros I, Silva A, de Almeida LP, Miranda CO. Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy. Cytokine Growth Factor Rev 2021;58:114-33. [PMID: 33397585 DOI: 10.1016/j.cytogfr.2020.12.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
196 Li J, Wang X, Li N, Jiang Y, Huang H, Wang T, Lin Z, Xiong N. Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review. Curr Gene Ther. 2020;20:285-288. [PMID: 32867652 DOI: 10.2174/1566523220999200820172829] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
197 Ellison-Hughes GM, Colley L, O'Brien KA, Roberts KA, Agbaedeng TA, Ross MD. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System.Front Cardiovasc Med. 2020;7:602183. [PMID: 33363221 DOI: 10.3389/fcvm.2020.602183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
198 Millar JE, Suen JY, McAuley DF, Fraser JF. Reply to Zhang and Hei: Mesenchymal Stem Cell-derived Exosomes: Are They Another Therapeutic Method for Extracorporeal Membrane Oxygenation-supported Acute Respiratory Distress Syndrome? Am J Respir Crit Care Med 2020;202:1603-4. [PMID: 32903045 DOI: 10.1164/rccm.202007-2995LE] [Reference Citation Analysis]
199 Zhang L, Hei F. Mesenchymal Stem Cell-derived Exosomes: Are They Another Therapeutic Method for Extracorporeal Membrane Oxygenation-supported Acute Respiratory Distress Syndrome? Am J Respir Crit Care Med 2020;202:1602-3. [PMID: 32903027 DOI: 10.1164/rccm.202007-2895LE] [Reference Citation Analysis]
200 Nguyen VVT, Witwer KW, Verhaar MC, Strunk D, van Balkom BWM. Functional assays to assess the therapeutic potential of extracellular vesicles. J Extracell Vesicles 2020;10:e12033. [PMID: 33708360 DOI: 10.1002/jev2.12033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
201 Gorman E, Millar J, McAuley D, O'Kane C. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential. Expert Rev Respir Med 2021;15:301-24. [PMID: 33172313 DOI: 10.1080/17476348.2021.1848555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
202 Xu HK, Chen LJ, Zhou SN, Li YF, Xiang C. Multifunctional role of microRNAs in mesenchymal stem cell-derived exosomes in treatment of diseases. World J Stem Cells 2020; 12(11): 1276-1294 [PMID: 33312398 DOI: 10.4252/wjsc.v12.i11.1276] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
203 Amigues I, Pearlman AH, Patel A, Reid P, Robinson PC, Sinha R, Kim AH, Youngstein T, Jayatilleke A, Konig M. Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation. Expert Rev Clin Immunol 2020;16:1185-204. [PMID: 33146561 DOI: 10.1080/1744666X.2021.1847084] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]
204 Massa M, Croce S, Campanelli R, Abbà C, Lenta E, Valsecchi C, Avanzini MA. Clinical Applications of Mesenchymal Stem/Stromal Cell Derived Extracellular Vesicles: Therapeutic Potential of an Acellular Product. Diagnostics (Basel) 2020;10:E999. [PMID: 33255416 DOI: 10.3390/diagnostics10120999] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
205 Harrell CR, Jovicic BP, Djonov V, Volarevic V. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome. Anal Cell Pathol (Amst) 2020;2020:1939768. [PMID: 33274176 DOI: 10.1155/2020/1939768] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
206 Feng Y, Huang J, Wu J, Xu Y, Chen B, Jiang L, Xiang H, Peng Z, Wang X. Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID-19 pneumonia: A pilot study. Cell Prolif. 2020;53:e12947. [PMID: 33205469 DOI: 10.1111/cpr.12947] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
207 Askenase PW. COVID-19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies? J Extracell Vesicles 2020;10:e12004. [PMID: 33304473 DOI: 10.1002/jev2.12004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
208 Rezakhani L, Kelishadrokhi AF, Soleimanizadeh A, Rahmati S. Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises. Chem Phys Lipids 2021;234:105009. [PMID: 33189639 DOI: 10.1016/j.chemphyslip.2020.105009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
209 Lin F, Ichim TE, Pingle S, Jones LD, Kesari S, Ashili S. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome. World J Stem Cells 2020; 12(10): 1067-1079 [PMID: 33178392 DOI: 10.4252/wjsc.v12.i10.1067] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
210 Li Z, Niu S, Guo B, Gao T, Wang L, Wang Y, Wang L, Tan Y, Wu J, Hao J. Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis. Cell Prolif 2020;53:e12939. [PMID: 33098357 DOI: 10.1111/cpr.12939] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
211 de Jong B, Barros ER, Hoenderop JGJ, Rigalli JP. Recent Advances in Extracellular Vesicles as Drug Delivery Systems and Their Potential in Precision Medicine. Pharmaceutics 2020;12:E1006. [PMID: 33105857 DOI: 10.3390/pharmaceutics12111006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
212 Caobi A, Nair M, Raymond AD. Extracellular Vesicles in the Pathogenesis of Viral Infections in Humans. Viruses 2020;12:E1200. [PMID: 33096825 DOI: 10.3390/v12101200] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
213 Cheng L, Li H, Li L, Liu C, Yan S, Chen H, Li Y. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal 2020;34:e23618. [PMID: 33078400 DOI: 10.1002/jcla.23618] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 19.5] [Reference Citation Analysis]
214 Al-Khawaga S, Abdelalim EM. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients. Stem Cell Res Ther 2020;11:437. [PMID: 33059757 DOI: 10.1186/s13287-020-01963-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
215 Yadav P, Vats R, Bano A, Bhardwaj R. Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics.Life Sci. 2020;263:118588. [PMID: 33049279 DOI: 10.1016/j.lfs.2020.118588] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
216 Golchin A. Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility. Stem Cell Rev Rep. 2021;17:56-62. [PMID: 33009982 DOI: 10.1007/s12015-020-10046-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
217 Bang OY. Coronavirus disease in 2020 and Precision and Future Medicine. Precis Future Med 2020;4:81-2. [DOI: 10.23838/pfm.2020.00135] [Reference Citation Analysis]
218 Li C, Zhao H, Wang B. Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19. Drug Des Devel Ther 2020;14:3995-4001. [PMID: 33061304 DOI: 10.2147/DDDT.S269407] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
219 Mahajan A, Bhattacharyya S. A brief review on potential application of mesenchymal stem cell and secretome in combating mortality and morbidity in COVID-19 patients. Biomed J 2021;44:63-73. [PMID: 33727050 DOI: 10.1016/j.bj.2020.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
220 Frazier T, Alarcon A, Wu X, Mohiuddin OA, Motherwell JM, Carlsson AH, Christy RJ, Edwards JV, Mackin RT, Prevost N, Gloster E, Zhang Q, Wang G, Hayes DJ, Gimble JM. Clinical Translational Potential in Skin Wound Regeneration for Adipose-Derived, Blood-Derived, and Cellulose Materials: Cells, Exosomes, and Hydrogels. Biomolecules 2020;10:E1373. [PMID: 32992554 DOI: 10.3390/biom10101373] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
221 Klimczak A. Perspectives on mesenchymal stem/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19. World J Stem Cells 2020; 12(9): 1013-1022 [PMID: 33033561 DOI: 10.4252/wjsc.v12.i9.1013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
222 Woods N, MacLoughlin R. Defining a Regulatory Strategy for ATMP/Aerosol Delivery Device Combinations in the Treatment of Respiratory Disease. Pharmaceutics 2020;12:E922. [PMID: 32993197 DOI: 10.3390/pharmaceutics12100922] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
223 Alzahrani FA, Saadeldin IM, Ahmad A, Kumar D, Azhar EI, Siddiqui AJ, Kurdi B, Sajini A, Alrefaei AF, Jahan S. The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients. Stem Cells Int 2020;2020:8835986. [PMID: 33014070 DOI: 10.1155/2020/8835986] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
224 Pocsfalvi G, Mammadova R, Ramos Juarez AP, Bokka R, Trepiccione F, Capasso G. COVID-19 and Extracellular Vesicles: An Intriguing Interplay. Kidney Blood Press Res. 2020;45:661-670. [PMID: 32957112 DOI: 10.1159/000511402] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
225 Maron-Gutierrez T, Rocco PRM. Cell-Free Therapies: Novel Approaches for COVID-19. Front Immunol 2020;11:583017. [PMID: 33072130 DOI: 10.3389/fimmu.2020.583017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
226 Borlongan MC, Borlongan MC, Sanberg PR. The Disillusioned Comfort with COVID-19 and the Potential of Convalescent Plasma and Cell Therapy. Cell Transplant 2020;29:963689720940719. [PMID: 32841042 DOI: 10.1177/0963689720940719] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
227 Brave H, MacLoughlin R. State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery. Int J Mol Sci 2020;21:E6435. [PMID: 32899381 DOI: 10.3390/ijms21176435] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
228 Fu EL, Janse RJ, de Jong Y, van der Endt VHW, Milders J, van der Willik EM, de Rooij ENM, Dekkers OM, Rotmans JI, van Diepen M. Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis. Clin Kidney J 2020;13:550-63. [PMID: 32897278 DOI: 10.1093/ckj/sfaa160] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
229 Jayaramayya K, Mahalaxmi I, Subramaniam MD, Raj N, Dayem AA, Lim KM, Kim SJ, An JY, Lee Y, Choi Y, Raj A, Cho SG, Vellingiri B. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment. BMB Rep 2020;53:400-12. [PMID: 32731913 [PMID: 32731913 DOI: 10.5483/bmbrep.2020.53.8.121] [Cited by in Crossref: 11] [Article Influence: 5.5] [Reference Citation Analysis]
230 Kothari A, Singh V, Nath UK, Kumar S, Rai V, Kaushal K, Omar BJ, Pandey A, Jain N. Immune Dysfunction and Multiple Treatment Modalities for the SARS-CoV-2 Pandemic: Races of Uncontrolled Running Sweat? Biology (Basel) 2020;9:E243. [PMID: 32846906 DOI: 10.3390/biology9090243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
231 Choudhery MS, Harris DT. Stem cell therapy for COVID-19: Possibilities and challenges. Cell Biol Int. 2020;44:2182-2191. [PMID: 32767687 DOI: 10.1002/cbin.11440] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 15.0] [Reference Citation Analysis]
232 Shafiee A, Moradi L, Lim M, Brown J. Coronavirus disease 2019: A tissue engineering and regenerative medicine perspective. Stem Cells Transl Med. 2021;10:27-38. [PMID: 32820868 DOI: 10.1002/sctm.20-0197] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
233 Laroye C, Gibot S, Huselstein C, Bensoussan D. Mesenchymal stromal cells for sepsis and septic shock: Lessons for treatment of COVID-19. Stem Cells Transl Med 2020;9:1488-94. [PMID: 32808462 DOI: 10.1002/sctm.20-0239] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
234 Hamdan H, Hashmi SK, Lazarus H, Gale RP, Qu W, El Fakih R. Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome? Blood Rev 2021;46:100742. [PMID: 32854985 DOI: 10.1016/j.blre.2020.100742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Guzman NA, Guzman DE. A Two-Dimensional Affinity Capture and Separation Mini-Platform for the Isolation, Enrichment, and Quantification of Biomarkers and Its Potential Use for Liquid Biopsy. Biomedicines 2020;8:E255. [PMID: 32751506 DOI: 10.3390/biomedicines8080255] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
236 Lisi L, Lacal PM, Barbaccia ML, Graziani G. Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2. Biochem Pharmacol 2020;180:114169. [PMID: 32710969 DOI: 10.1016/j.bcp.2020.114169] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
237 Forsberg MH, Kink JA, Hematti P, Capitini CM. Mesenchymal Stromal Cells and Exosomes: Progress and Challenges. Front Cell Dev Biol 2020;8:665. [PMID: 32766255 DOI: 10.3389/fcell.2020.00665] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
238 Guo Z, Chen Y, Luo X, He X, Zhang Y, Wang J. Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia. Crit Care. 2020;24:420. [PMID: 32653043 DOI: 10.1186/s13054-020-03142-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
239 Iwata T. PCR detection and new therapies for COVID-19. J Periodontal Implant Sci 2020;50:133-4. [PMID: 32617178 DOI: 10.5051/jpis.2020.50.3.133] [Reference Citation Analysis]
240 Saldanha-Araujo F, Melgaço Garcez E, Silva-Carvalho AE, Carvalho JL. Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment. Front Immunol 2020;11:1563. [PMID: 32719683 DOI: 10.3389/fimmu.2020.01563] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
241 Muraca M, Pessina A, Pozzobon M, Dominici M, Galderisi U, Lazzari L, Parolini O, Lucarelli E, Perilongo G, Baraldi E. Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia? J Control Release 2020;325:135-40. [PMID: 32622963 DOI: 10.1016/j.jconrel.2020.06.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
242 Mir B, Goettsch C. Extracellular Vesicles as Delivery Vehicles of Specific Cellular Cargo. Cells 2020;9:E1601. [PMID: 32630649 DOI: 10.3390/cells9071601] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
243 Lim SK, Giebel B, Weiss DJ, Witwer KW, Rohde E. Re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19" by Sengupta et al. Stem Cells Dev 2020;29:877-8. [PMID: 32520641 DOI: 10.1089/scd.2020.0089] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
244 Sengupta V, Sengupta S, Lazo A Jr, Hicok KC, Moseley T. Response to Lim et al. re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19". Stem Cells Dev 2020;29:879-81. [PMID: 32520639 DOI: 10.1089/scd.2020.0095] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]